Immunovant IMVT
NASDAQ IMVT
$28.36 -0.23 (-0.79%)
As of: Oct 21, 2026 · 3:59 PM EDT

Immunovant (IMVT) Times Interest Earned (2019)

Updated

Immunovant's Times Interest Earned was -105.07 in FY2020 (year ended Mar 31, 2020).

Analysis

Immunovant (IMVT) Times Interest Earned (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immunovant 5.85 Bn 2.63 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -28.78
Sep 30, 2019 -1.69
API Access

Immunovant Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=IMVT&period=max&api_key=YOUR_API_KEY